Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous Iron Carboxymaltose vs Iron Isomaltoside vs Oral Iron Sulphate for Postpartum Anemia
NCT03957057Phase 3Completed
- Sponsor
- University Medical Centre Ljubljana
- Start
- Sep 2020
- Primary completion
- Apr 2022
- Modality
- Inorganic Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of ferric carboxymaltose and ferric derisomaltose in postpartum anemia (3 arms), sponsored by University Medical Centre Ljubljana. Primary endpoint: Multidimensional Fatigue Inventory at 6 weeks. Started Sep 2020; status: completed.
02
Drugs
ferric carboxymaltoseferric derisomaltose
03
Conditions
postpartum anemia
Beyond the preview
Go deeper on NCT03957057.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03957057.